Bio & Health Tech Events in Europe

Fresh perspectives. New connections. Real impact. Meet researchers, industry leaders and innovators shaping veterinary innovation.

THE NEXT CHAPTER STARTS HERE.

Great research deserves real-world impact. And innovation starts when the right people connect.

On 9 November, we're bringing together bright minds, bold ideas and key players from research, industry and the innovation ecosystem to celebrate the relaunch of VetWIDI – the innovation hub of the University of Veterinary Medicine Vienna.

VetWIDI is entering an exciting new chapter. We're building stronger bridges between science and industry, turning promising research into real-world applications and creating new opportunities for collaboration, investment and entrepreneurship.

And we'd love you to be part of it.

WHAT'S HAPPENING?

💡 FRESH IDEAS. REAL POTENTIAL.

Discover four promising research projects as Vetmeduni teams take the stage to pitch their innovations.

🎤 THE FUTURE OF VETERINARY MEDICINE.

Hear from industry leaders as they explore emerging trends, untapped opportunities and the future of veterinary and One Health innovation.

🤝 MEET THE PEOPLE WHO MAKE INNOVATION HAPPEN.

Connect with researchers, industry representatives, entrepreneurs, investors and decision-makers from across the innovation ecosystem.

Exchange ideas, discover opportunities and spark collaborations – over drinks and a buffet.

MORE THAN A RELAUNCH.

This is about bringing the right people together, unlocking the potential of veterinary and One Health research, and shaping what comes next.

New ideas. New partnerships. New possibilities.

WHO SHOULD ATTEND?

Whether you're developing the next breakthrough, looking for new technologies or seeking the right partners to make innovation happen – this event is for you.

🔬 RESEARCHERS & INNOVATORS

Ready to take your ideas beyond the lab and turn research into real-world applications.

🏢 INDUSTRY LEADERS & CORPORATES

Looking for new technologies, research collaborations and opportunities in animal health, pharma, diagnostics, food and tech.

🚀 INVESTORS & FUNDING ORGANISATIONS

Interested in promising innovations, emerging ventures and the potential of veterinary and One Health research.

🤝 ENTREPRENEURS & ECOSYSTEM PARTNERS

Connecting science, business and innovation to create impact.

GETTING THERE

📍 VENUE

University of Veterinary Medicine Vienna (Vetmeduni)

Lecture Hall G, Building LA

Veterinärplatz 1, 1210 Vienna, Austria

Signs on campus will guide you to the registration desk.

🚋 PUBLIC TRANSPORT (RECOMMENDED)

U6 or S-Bahn to Floridsdorf, then tram 25 or 26.

Alternatively, take the U1 to Kagran or Kagraner Platz, followed by tram 26 or bus 27A.

🚗 PARKING

Paid parking is available directly on campus.

🔗 DIRECTIONS

https://www.vetmeduni.ac.at/en/university/campus/directions

QUESTIONS?

Feel free to contact us at innovation@vetwidi.com.

We look forward to welcoming you!

AI for Health: Jak umělá inteligence mění zdravotnictví

Umělá inteligence stále více nachází využití v diagnostice, zdravotní péči i při zefektivňování procesů.
AI for Health propojí zdravotníky, technologické inovátory a zástupce pacientů, aby společně představili praktické aplikace AI, diskutovali její příležitosti i rizika a hledali podmínky pro její odpovědné a důvěryhodné využití. Akce je součástí festivalu Dny AI, který pořádá prg.ai.

Pro koho je akce určena?
🩺 Zdravotničtí profesionálové
Pro všechny, kteří chtějí lépe rozumět tomu, jak může AI pomoci s diagnostikou, péčí o pacienty a každodenními pracovními procesy.

💻 Vývojáři AI a technologičtí inovátoři
Pro odborníky, kteří se chtějí seznámit se specifickými potřebami, výzvami a regulatorním prostředím zdravotnictví.
👥 Pacienti a pacientské organizace
Pro ty, které zajímá dopad AI na zkušenost pacientů, bezpečné využívání dat a kvalitu péče.
🎓 Odborná veřejnost a studenti
Pro všechny, kteří sledují trendy na pomezí medicíny, technologií a inovací ve zdravotnictví.

Co vás čeká?
Po úvodním slovu nabídne program sérii krátkých lightning talks. Zazní pohled Technologického centra MSD v Praze, pacientská perspektiva Kristýny Čillíkové z České aliance pro kardiovaskulární onemocnění a pohled mladých lékařů zastoupený MUDr. Albertem Štěrbou. Praktická řešení představí také zástupci společností Linet, Auris One a MAIA.

Na krátká vystoupení naváže panelová diskuse moderovaná Evou Karáskovou, ředitelkou pro vnější vztahy MSD v ČR. Zaměří se na konkrétní využití AI v diagnostice a péči, očekávání a obavy pacientů i zdravotníků a na otázky důvěry, dezinformací, transparentnosti a odpovědného zavádění AI do praxe. Součástí večera bude také prostor pro dotazy publika, praktické ukázky řešení a networking.

Harmonogram akce
16:30–17:00 – Registrace a příchod hostů
17:00–17:05 – Úvodní slovo a představení partnerství s prg.ai
17:05–17:45 – Lightning talks
17:45–18:45 – Panelová diskuse
18:45–19:00 – Q&A
19:00–20:00+ – Praktické ukázky a networking
Kdy?

📅 10. listopadu 2026
🕟 16:30–20:30
🗣️ Akce proběhne v češtině.

Jak se přihlásit?
Registrovat se můžete na tomto odkazu,

Upozornění: Během akce mohou být pořizovány fotografie a krátká videa pro účely propagace (webové stránky, sociální sítě, newslettery apod.). Pokud si nepřejete být fotografováni nebo natáčeni, informujte prosím organizátory při příchodu a uděláme maximum pro respektování vašeho přání.

Discover how Medtronic is building digital and cloud native software technology in Ireland that is shaping the future of patinet care.

The Digital Heartbeat Tech Talks With Medtronic

Dublin Edition

After two sell-out events at the PorterShed in Galway, Medtronic’s ‘The Digital Heartbeat Tech Talks’ series is going on the road for the first time. This November, we are bringing the series to Dublin for an evening designed for software, cloud, data, AI, systems, product, and digital technology professionals who want their work to make a meaningful difference at global scale.

Join senior engineering leaders from Medtronic and connect with Dublin’s tech community to explore how cloud-native platforms are shaping the future of patient care. Discover what it means to build digital solutions where reliability, zero-downtime resiliency, and innovation directly support life-critical clinical outcomes.

• Date: Tuesday, 10th November, 2026
• Location: The Market Bar, Fade Steet, Dublin 2
• Time: 6:30 PM – 8:30 PM (Tech Talks start at 7:00 PM)

About the Event:

Building on the momentum of our first two session at the PorterShed, this event expands the conversation across both Medtronic’s Patient Care Systems (PCS) and Digital Interventional Cardiology Therapies (ICT) teams.

We will explore how specialised clinical technology and modern cloud platforms intersect to power the next generation of connected healthcare. You will hear directly from engineering and technical leaders about how cloud-native platforms, connected systems and data-driven intelligence are shaping the future of patient care. This is a chance to discover what it means to build digital solutions where reliability, security and innovation can directly support better clinical outcomes.

Why Attend?

• Technology with purpose: See how modern software, cloud architecture, and connected platforms are being applied to complex healthcare challenges.
• Clinical and patient perspective: Hear how technology moves from code and platform decisions into real clinical settings and patient experiences.
• Insights from Medtronic teams: Learn how the Patient Care Systems and Digital Interventional Cardiology Therapies teams are advancing connected care and scaling digital health platforms across Ireland and globally.
• Dublin Tech Networking: Connect with local developers, architects, and product leads, as well as Medtronic’s engineering teams over complimentary finger food, craft beers, wine, and soft drinks on Fade Street.
• Open conversation: Take part in a moderated panel discussion and audience Q&A on the future of connected health, AI and meaningful tech.

Speakers & Host:

• Paul Mearns: Sr. Director, Patient Care Systems (PCS), Medtronic
• David Formisano: VP, Digital Interventional Cardiology Therapies (ICT) Group, Medtronic
• Anne Tierney: Cardiac Physiologist, St. Vincent’s Private Hospital
• MC / Moderator: Aoibhinn Ní Shúilleabháin (Academic | Science Communicator | Broadcaster)

Agenda:

• 18:30 – 19:00 | Arrival & Networking: Craft beer, wine, soft drinks, and finger food served in a relaxed setting.
• 19:00 – 19:10 | Welcome & Opening Remarks: Paul Mearns on architecting and scaling global digital health platforms from Ireland.
• 19:10 – 19:30 | Panel Discussion: The Future of Connected Health & Digital Platforms, moderated by Aoibhinn Ní Shúilleabháin. A frank discussion on cloud scale, reliability, engineering culture, and technical hurdles.
• 19:30 – 19:45 | Open Q&A
• 19:45 – 20:30 | Networking & Informal Mixer: Grab another drink, chat with the speakers, and meet the engineering teams to discover what building software at Medtronic is really like.
• 20:30 | Event Close

About Medtronic’s Digital Health Engineering Teams:

Innovation happens where clinical domain expertise meets scalable, enterprise digital platforms. Our Patient Care Systems (PCS) team builds the secure, cloud-native architecture for continuous remote cardiac monitoring, while our Digital Interventional Cardiology Therapies (ICT) group delivers data-driven intelligence directly into acute care workflows.

Together, these teams push the boundaries of what’s possible in connected medical technology, ensuring that lifesaving telemetry data is processed reliably when every second counts. If you are curious about what software engineering looks like at Medtronic and want to build tech that genuinely matters, come network with our team.

For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

Registration

Attendance is free, but capacity at The Market Bar is strictly limited. Reserve your spot early to join us for our Dublin debut!

Autodeterminazione, partecipazione e qualità della vita per le persone con disabilità

Helpimeeting 2026 è dedicata al ruolo delle Tecnologie Assistive Digitali (TAD) nel promuovere l'autodeterminazione, la partecipazione e il miglioramento della qualità della vita delle persone con disabilità.

E' un'importante occasione di confronto tra

• professionisti della riabilitazione
• medici prescrittori
• terapisti occupazionali
• logopedisti,
• educatori,
• insegnanti,
• familiari,
• decisori amministrativi

per condividere esperienze, evidenze scientifiche e innovazioni tecnologiche che stanno trasformando il mondo delle TAD.

AGENDA

• ore 10.00 inizio dei lavori
• ore 11.30 pausa caffè
• ore 13.00 pausa pranzo libera
• ore 14.00 ripresa dei lavori
• ore 16.00 conclusione

I temi contrali di questa edizione:

➞ L'impatto delle Tecnologie Assistive Digitali sulla qualità della vita, attraverso soluzioni che favoriscono autonomia, benessere e partecipazione nei diversi contesti di vita.

➞ Autodeterminazione e autonomia, grazie alle tecnologie che consentono alle persone di esprimere le proprie scelte, comunicare, prendere decisioni e partecipare attivamente alla vita quotidiana, dando voce alla propria volontà in ogni fase dell'esistenza.

➞ Il superamento delle barriere giuridiche e amministrative, analizzando come le Tecnologie Assistive Digitali possano rappresentare strumenti concreti per garantire l'esercizio dei diritti, l'accesso ai servizi e una reale uguaglianza di opportunità.

➞ Partecipazione e inclusione, con un focus sul ruolo delle Tecnologie Assistive Digitali nel favorire la piena partecipazione alla scuola, al lavoro, alla vita sociale e al tempo libero. Particolare attenzione sarà dedicata all'Assistive Gaming, sempre più riconosciuto come uno strumento di inclusione, socializzazione, capace di promuovere relazioni.

➞ Intelligenza Artificiale e Tecnologie Assistive Digitali, per esplorare come le nuove tecnologie basate sull'AI possano rendere gli ausili sempre più efficenti, personalizzabili e capaci di adattarsi alle esigenze della persona, migliorando l'accessibilità, la comunicazione e il supporto alle attività quotidiane.

➞ Comunicazione Aumentativa Alternativa (CAA), come elemento fondamentale per garantire il diritto alla comunicazione delle persone con bisogni comunicativi complessi. Saranno approfondite le più recenti evoluzioni degli strumenti simbolici e alfabetici e il loro ruolo nel favorire autodeterminazione, partecipazione e inclusione in tutti gli ambiti della vita

Le relazioni:

Intelligenza Artificiale per l’inclusione: riconoscimento vocale e comunicazione assistiva per persone con disabilità

➞ Nicola Gencarelli - Pedagogista esperto di TAD, Responsabile Ricerca Tecnologica per l’innovazione sociale, Fondazione ASPHI ETS

Progetto ITACA: impatto sociale dell'uso delle tecnologie assistive digitali in Italia.

➞ Marco Iosa - Professore Associato, Dipartimento di Psicologia, università di Roma La Sapienza

Progetto Lucilla, Un modello replicabile di autodeterminazione attraverso le Tecnologie Assistive Digitali

➞ Ada Covino - utilizzatrice TAD

Diritto alla scienza e diritti fondamentali della persona: il ruolo delle tecnologie assistive digitali

➞ Filomena Gallo - Avvocata cassazionista, Segretaria dell’Associazione Luca Coscioni per la libertà di ricerca scientifica APS

Assistive gaming, nuove possibilità per rendere i videogiochi accessibili e promuovere inclusione, partecipazione e relazione attraverso il gioco.

➞ Bob Sagoo - Product Specialist, Pretorian; membro del Direttivo di Communication Matters (ISAAC UK), Inghilterra

Come nasce un comunicatore dinamico dedicato? Quali sono i passaggi che portano alle scelte progettuali, costruttive e funzionali dell'ausilio?

➞ Nick Ward - Managing Director, Smartbox, Inghilterra

Autodeterminazione e protesica: la survey nazionale AITO sul recepimento e l'attuazione del “Nuovo Nomenclatore”.

➞ Gabriella Casu - Presidente AITO, Associazione Italiana di Terapia Occupazionale

Accessibilità "in quota": Comunicazione Aumentativa Alternativa e tecnologie digitali per una montagna inclusiva.

➞ Matteo Cantoni - Terapista Occupazionale, Coordinatore del Servizio di Terapia Occupazionale, Psicomotricità e PsicoEducativo, Centro Cardinal Ferrari

CAA e autodeterminazione: CAA e autodeterminazione: il diritto di Gaia a esprimersi in tribunale attraverso il proprio comunicatore dinamico

➞ Roberta Cristofani - Terapista occupazionale esperta di CAA

Brancher un LLM sur des données clients, tout le monde sait faire.
Le brancher sur des données médicales, c’est autre chose.

Hébergement européen, zéro rétention, évals à chaque itération : aucune marge d’erreur.

Chez Qare, chaque minute qu’un médecin passe sur de l’admin est une minute de moins avec ses patients. Pas de lab IA, pas de POC qui dort dans un tiroir.

4 features construites pour les praticiens, dont 3 en prod, sous les contraintes les plus dures qui existent sur la donnée.

Maxime Sraiki est CTO de Qare. Le jeudi 12 novembre 2026, il ouvre le capot, screenshots et métriques à l’appui. Il racontera aussi ce que son équipe referait autrement.

Voici ce qu’on va couvrir :

1. Smart Calendar : du machine learning pour guider les médecins
2. Clinical Note-taker : LLM & données médicales
3. Symptom checker : Préparer la consultation avant qu’elle commence
4. Signalements comportement abusif : Workflow construit par l’équipe Ops avec LLM ZDR & EUR

🎒 Tu repartiras avec :
→ Une méthode pour envoyer des données sensibles à un LLM sans rogner sur la conformité
→ Une approche d’évaluation d’un LLM en prod, transposable hors santé

📺 Jeudi 12 novembre 2026, 12h00
Format : 60 min, masterclass + Q&A en direct, animé par Emma Goldblum

Join founders and innovators working to improve male reproductive health. Connect with the community, share ideas, and enjoy wine and pizza.

🧬 What if we could give men more control over their reproductive health, from new contraceptive options to innovative treatments for infertility?

🎉 Join us for the next Ventures & Wine, an evening dedicated to men’s health in recognition of November as Men’s Health Awareness Month!

📅 Thursday, November 12th, 2026 | 17:00–20:00📍 Symbion Østerbro, Copenhagen

This time, we are bringing together two Danish startups developing innovative solutions in male reproductive health.

Our guest speakers will take us behind the science of their technologies and share their experiences, challenges, and insights from turning scientific ideas into real-world solutions.

Expect an evening of science, startup stories, honest conversations, new connections, and, of course, wine, drinks, and pizza.

📣 Speakers:

Lasse Nørregaard — Co-founder and CBO, XY Therapeutics➜ Developing a novel treatment for male infertility, aiming to improve sperm production and function.

Niels Lindeburg — Founder and CTO, VasDeBlock Medical➜ Developing a hormone-free, non-surgical, and reversible male contraceptive alternative to vasectomy.

🎟️ Register now here on Eventbrite

🍷 Why Join?

• Discover innovative technologies addressing male reproductive health• Hear directly from entrepreneurs bringing new medical solutions to life• Connect with scientists, entrepreneurs, and industry professionals• Enjoy wine, pizza, and good conversations

🤝 About Ventures & Wine

Ventures & Wine is a monthly networking and inspiration event by REBBLS, connecting scientists, entrepreneurs, and industry professionals across the life science community.

This session is supported by BioInnovation Institute (BII), KU Lighthouse, VinFraLoire, HØIBERG – European Patent Attorneys, and Symbion Community.

Discover how you can see your tissue samples in a whole new dimension and unlock deeper biological insights with 2D and 3D imaging

The Biomedicum Imaging Core (BIC) at Karolinska Institute (KI) and Miltenyi Biotec Nordics invite you to a scientific seminar exploring the latest advances in 2D and 3D imaging and their potential to reveal more from your samples.

From high-plex spatial profiling with the MACSima® platform to 3D visualization with the UltraMicroscope Blaze™, these technologies are already available at BIC and ready to support your research.

Discover new ways to explore spatial organization, cellular interactions, and tissue architecture across fields including immunology, neuroscience, drug discovery, and beyond.

Whether you are looking for inspiration for your next experiment or simply curious about what is possible, join us to explore, learn, and connect with experts and fellow researchers.

When: Monday, 16 November , 2026

Time: 12:00 - 18:00

Where: Eva & Georg Klein Room, Biomedicum, Karolinska Institute, Stockholm

12:00 - 13:00 - Lunch and Mingling

13:00 - 13:15 - Welcome and Introduction | BIC and Miltenyi Biotec Nordics

13:15 - 13:45 - Mapping Cancer in Space: How Spatial Multiomics is Changing Translational Research | Sophia Scheuermann - University Hospital Tübingen, Germany

13:45 - 14:15 - One Cell. One Place. One Story. | Xiang Zheng - Aarhus University; University of Copenhagen

14:15 - 14:45 - Fika break

14:45 - 15:05 - Light‑Sheet–Based 3D Reconstruction of Islet Landscapes Across the Pancreas | Ulf Ahlgren - Umeå University, Sweden

15:05 - 15:25 - Three-Dimensional Mapping of RNA Expression Across Intact Tissues and Whole Organs | Per Uhlén - Karolinska Institute, Sweden

15:25 - 15:45 - Title TBD | Bengt Mattsson - Lund University, Sweden

15:45 - 16:05 - Spatial Mapping of the Tonsillar Immune Landscape | Mattias Svensson - Karolinska Institute, Sweden

16:05 - 16:25 - Immunoprofiling human skin in atopic dermatitis using the MACSima platform. | Marta López Montes, Karolinska Institute, Sweden

16:25 - 16:30 - Closing remarks

16:30 - 18:00 - Mingle and Networking

Please let us know if you can't attend the seminar, either after registering or closer to the event, so we can adjust our preparations, reduce food waste, and respect nature.

*This educational event is free of charge and open to attendance by practicing scientists from Academia and Industry. Lunch and refreshments will be served.

**Please be advised that you are entering an area where you may be in a background of video, photo or audio recording. These recordings may be used and published for marketing and PR purposes. If you are the focus of the recording your explicit consent will be requested separately. For general information on the use of your personal information by Miltenyi, please see Miltenyi’s Privacy Statement (www.miltenyibiotec.com/privacy).

Biotech Connect Leipzig × Nucleate Germany - November Edition

This month we host the stage together with 𝗡𝘂𝗰𝗹𝗲𝗮𝘁𝗲 𝗚𝗲𝗿𝗺𝗮𝗻𝘆. Meet 𝗗𝗿. 𝗨𝗹𝗿𝗶𝗸𝗲 𝗗𝗶𝗲𝘀𝘁𝗲𝗿𝗯𝗲𝗰𝗸, Managing Director of 𝗩𝗘𝗥𝗢𝗩𝗔𝗖𝗖𝗶𝗡𝗘𝗦, on taking a university vaccine platform from 𝗛𝗮𝗹𝗹𝗲 to 𝗘𝗨-𝘄𝗶𝗱𝗲 𝗺𝗮𝗿𝗸𝗲𝘁 𝗮𝘂𝘁𝗵𝗼𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻.

📅 Tuesday, November 15
⏰ Door 19:00 · Talk 19:15
📍 Basislager Coworking, Peterssteinweg 14, Leipzig

𝗡𝘂𝗰𝗹𝗲𝗮𝘁𝗲 𝗚𝗲𝗿𝗺𝗮𝗻𝘆
Nucleate is a free, non-profit organization run by trainees, with chapters in over 40 regions. Its 𝗔𝗰𝘁𝗶𝘃𝗮𝘁𝗼𝗿 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 takes scientific founding teams through months of company-building, ending in a demo day with investors and industry. 𝗪𝗲 𝘀𝗵𝗮𝗿𝗲 𝗼𝗻𝗲 𝗴𝗼𝗮𝗹: 𝗺𝗼𝗿𝗲 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀 𝘁𝘂𝗿𝗻𝗶𝗻𝗴 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻𝘁𝗼 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀. We open the evening together, as the 𝗳𝗶𝗿𝘀𝘁 𝘀𝘁𝗲𝗽 𝗼𝗳 𝗼𝘂𝗿 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻.

𝗩𝗘𝗥𝗢𝗩𝗔𝗖𝗖𝗶𝗡𝗘𝗦
A spin-off of Martin Luther University 𝗛𝗮𝗹𝗹𝗲-Wittenberg, VEROVACCiNES develops animal vaccines on 𝗼𝗻𝗲 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺: fast to develop, 𝗵𝗲𝗮𝘁-𝘀𝘁𝗮𝗯𝗹𝗲 𝗮𝗻𝗱 𝗹𝗼𝘄-𝗰𝗼𝘀𝘁. In April 2026 its first product, 𝗩𝗲𝗿𝗼𝗕𝗹𝘂𝗲-𝟯 against bluetongue, received 𝗘𝗨-𝘄𝗶𝗱𝗲 𝗺𝗮𝗿𝗸𝗲𝘁 𝗮𝘂𝘁𝗵𝗼𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻. The company also signed its 𝗳𝗶𝗿𝘀𝘁 𝗼𝘂𝘁-𝗹𝗶𝗰𝗲𝗻𝘀𝗶𝗻𝗴 𝗱𝗲𝗮𝗹 with a top-10 global animal health company. After a 𝗺𝗶𝗱-𝘀𝗲𝘃𝗲𝗻-𝗳𝗶𝗴𝘂𝗿𝗲 𝗦𝗲𝗿𝗶𝗲𝘀 𝗕 in 2021, existing investors and the founders largely followed on with €𝟭.𝟲𝗠 in 2025.

𝗨𝗹𝗿𝗶𝗸𝗲 will tell the story behind it: 𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗩𝗲𝗿𝗼𝗕𝗹𝘂𝗲-𝟯: 𝗙𝗿𝗼𝗺 𝗛𝗮𝗹𝗹𝗲 𝘁𝗼 𝗠𝗮𝗿𝗸𝗲𝘁. Then questions, pizza and open networking.

Why we meet
Leipzig and Saxony are home to world-class life-science research. Too little of it becomes a company.

Ideas aren’t the missing piece. What’s often missing is the team around them: the researcher with the discovery, the engineer who can build it, the founder who has done it before, the investor who can back it. Those people rarely meet.

Biotech Connect Leipzig brings them into one room, every month.
Our goal: more biotech startups founded in this region, and a community strong enough to help them grow.

Follow us on LinkedIn
Join the Whatsapp Community

Practical workshop for founders, product owners/technical leads and QA/RA professionals developing medical device/IVD software.

This free, full-day workshop with Firefinch and Lucendra MedTech Consulting is designed to leave you with actionable insights to avoid costly rework, a clearer understanding of what regulators actually expect, and the confidence to move forward with the right plan for your device or IVD software.Practical software development for;

• Founders
• Product owners/technical leads
• QA professionals

developing software for medical devices or in vitro diagnostics.

Firefinch Software are developers, experts and strategists specialising in the life sciences.

Lucendra MedTech Consulting are engineers, scientists and business professionals with expertise across the whole device lifecycle, from design and validation through regulatory approval
to launch.

You’ll leave with:

• Actionable insights on avoiding rework
• A clearer understanding of regulatory expectations
• Confidence to move forward with the right plan
• A partner who can support you every step of the way

NB As places are limited, we may have to limit space to 1 per company.

Product qualification and classification; regulatory landscape in EU and US, commonalities and differences

What are the key process steps and what are the common mistakes to avoid

Integration of software development practices with medical device regulatory requirements

How the AI Act layers and integrates with MDR/IVDR

How to apply ISO 14971 to software, and how AAMI TIR 34971 can be used to facilitate risk management of AI/ML-enabled medical devices

Plus practical exercises on software architecture, safety classes and threat modelling.

You will also have time to ask the experts all the questions you may have.

A light lunch will be provided and certification will be provided to attendees that successfully complete the workshop.

This thought-leader discussion is about technologies that are disrupting the life sciences and health innovation sectors today & tomorrow

The Creative Disruption Forum is a high-level, interactive gathering built for executive leaders, senior researchers, startup founders, and biotech investors.

The Quantum Horizon Meets Real-World Science

We are witnessing a transformative shift in health innovation. While emerging paradigms like quantum computing promise to fundamentally redefine how we process biological complexity in the future, biopharma leaders today need actionable, deployable technologies to de-risk pipelines, accelerate drug discovery, and improve clinical outcomes now.

The Latest & Future Technologies Impacting Health Innovation and Life Sciences bridges the gap between tomorrow’s deep-tech horizons and today’s high-impact biological and computational breakthroughs. Hosted at ARC West London as a flagship London Life Sciences Week event, this interactive forum brings together biopharma executives, tech bio founders, investors, and academic leaders for unscripted, Chatham House Rules discussions on what is genuinely working, where the bottlenecks lie, and how to build scalable healthcare solutions.

From physical molecule-to-protein target engagement (such as CETSA® platforms) and human-relevant New Approach Methodologies (NAMs) to real-world AI applications in lead optimization, this event delivers an unfiltered "boots on the ground" look at modern translational science.

Why You Should Attend:

Ground Your Strategy in Real-World Tech: Move beyond theoretical hype to evaluate proven technologies transforming R&D pipelines today—including next-gen sequencing (NGS), advanced cell & gene therapies, and biophysical target-engagement assays.

De-Risk Your Clinical Pipeline: Discover how New Approach Methodologies (NAMs), organ-on-a-chip systems, and cellular shift assays are replacing legacy models, reducing Phase II/III failure rates, and delivering more efficacious molecules into the clinic.

Unfiltered "Boots on the Ground" Insights: Hear directly from SME CEOs and biopharma R&D directors on integrating AI into discovery pipelines—sharing candid case studies on what works, what has failed, and how to avoid costly missteps.

Connect Across the West Tech District: Engage directly with key anchors across West London’s innovation ecosystem, including Imperial College London, White City Innovation District, Paddington Life Sciences, Nexus, and ARC Group.

Actionable Peer-to-Peer Workshops: Participate in interactive afternoon breakout sessions designed to co-create practical strategies for scaling deep-tech venture navigating regulatory pathways for NAMs, and optimizing R&D data.

Who Should Attend:

• Biopharma & Biotech Executives (CEOs, CSOs, CTOs, R&D Directors): Looking to de-risk discovery pipelines, adopt next-generation analytical platforms, and integrate computational tools effectively.
• Tech Bio Founders & SME Leadership: Seeking real-world feedback on scaling ventures, securing investment, and overcoming wet-lab validation bottlenecks.
• Venture Capitalists & Deep-Tech Investors: Eager to identify high-growth opportunities across both near-term biopharma technologies and long-term deep-tech frontiers.
• Academic Researchers & Translational Scientists: Interested in commercializing spinouts and bridging the gap between basic research and clinical reality.
• Clinical & Regulatory Leaders: Exploring FDA/MHRA roadmaps for NAM adoption, advanced diagnostics, and cell/gene therapy pathways.

Draft Agenda

09:00 AM – 09:45 AM | Registration, Breakfast & Networking

Arrival, registration, and informal networking over breakfast.

09:45 AM – 10:00 AM | Welcome and sponsor thank yous

• Welcome: Deb Spencer (ARC West London)
• Opening Address: Prof Tony Sedgwick & Graham Combe

10:00 AM – 10:45 AM | Opening Keynote Panel: The Future Promise of Quantum & Deep Tech in Healthcare - Adam Hammond, Head of Quantum EMEA, IBM, Anshu Bansal, Imperial College and London Quantum Cluster and Algorithmic (TBC).

10.45 AM - 11.30 am : De-Risking Pipelines — Target Engagement & New Approach Methodologies (NAMs)

Unpacking intracellular target engagement in live cells (e.g., CETSA® and biophysical mass spectrometry) alongside microphysiological systems (organ-on-a-chip, 3D organoids) to confirm compound binding and improve translational success before clinical entry.

• Keynote interviews including Michael Dabrowski, CEO, Pelago Bioscience AB

11:30 AM – 12:00 PM | Keynote Panel: What Is Being Funded Today vs. Tomorrow?

Top VCs and life science investors discuss capital allocation across biological platforms, NAMs, and computational deep-tech, detailing how target-engagement data impacts valuation and Series funding.

12:00 PM – 12:30 PM | Refreshments & Networking Break

12:30 PM – 1.00 PM | Fireside Keynote Interview with Edwin Moses, Chairman, LabGenius, Avantium AV and Nanosyrinx.

1:00 PM – 1:30 PM | Boots on the Ground: SME & Startup CEO Showcase

Fast-paced spotlight presentations and candid feedback from high-growth Tech Bio founders sharing practical case studies on hit identification, assay bottlenecks, and lessons learned from unsuccessful trials.

01:30 PM – 02:30 PM | Networking Lunch

02:30 PM – 03:45 PM | Interactive Workshop Breakouts

• Track 1: Deploying AI & CETSA/Biophysical Assays in R&D Pipelines — Closing the gap between in silico predictions and physical binding.
• Track 2: Translational Regulatory Pathways for NAMs & Organ-on-a-Chip — Working with regulators (FDA/MHRA) to reduce animal testing and speed up clinical entry.
• Track 3: Scaling Deep Tech & Bio Ventures in West London — Infrastructure, lab space, capital, and ecosystem growth across the West Tech District.
• Track 4: Regulatory considerations and challenges regarding using the latest technologies to develop your innoavtion
• Track 5: Data considerations in a modern life sciences innovation company.
• Track 6: Considerations when scalling up and building your company dream team.

03:45 PM – 04:30 PM | Workshop Closing & Executive Summary

Synthesis of workshop takeaways, actionable strategies, and policy insights for sector leaders.

04:30 PM – 08:30 PM | Champagne Evening Reception, Keynote Talk & Networking - Adam Hammond, Head of Quantum, IBM

Champagne drinks reception and evening keynote designed to build lasting partnerships across the tech, healthcare, and life sciences ecosystem.

We promise that our #CreativeDisruption Forum will be like no other life sciences event or business network you have experienced. You will be walking out of the session inspired, educated and more connected.

ADMISSION FEE for Service Companies such as CROs, CDMOs, Law Firms and Patent Attorneys, Consultancy Firms = £150 - ALL-INCLUSIVE

ADMISSION FEE for Innovative Emerging Life Science Companies and Independent Consultants = £80

Investors can apply for free entry by writing to graham@biosell.co.uk.

Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface. CDD helps scientists register entities, track inventory, manage assay data, capture experiments, calculate Structure-Activity Relationships (SAR), and mine their data for drug candidates. CDD was founded in 2004 and presently serves thousands of researchers doing drug discovery all around the world. Learn more atwww.collaborativedrug.com

ARC West London is a dynamic hub for innovation, located on the scenic riverside in Hammersmith, at the heart of West Tech London – one of the UK’s fastest-growing life sciences and tech clusters. Designed for companies at every stage of their journey, the campus offers a seamless pathway from concept to commercial success.

Start with Leap our incubator labs, run by Imperial Incubator, perfect for early-stage breakthroughs. Accelerate progress in Motherlabs, our fully serviced, flexible accelerator labs that removes the barriers to scaling. Then thrive in our grow-on fitted lab space or shell and core space, tailored for expanding teams and advanced R&D. For growing or established organisations, ARC West London also offers HQ-quality office space, enabling you to bring your science, leadership, and commercial teams together under one roof.

With direct connections to central London, Heathrow, and leading research institutions, the campus puts you in easy reach of world-class talent, collaborators, and investors. Add riverside views, high-quality amenities, Imperial and NHS partnerships, a curated programme of events and a vibrant community of pioneering companies, and you have a place where ideas aren’t just developed, they’re accelerated.

Company: Pelago Bioscience AB

Senior Management Team: Michael Dabrowski, founder and CEO; Daniel Martinez-Molina, founder and CSO; Kia Pedersen, COO. Company founded: 2013

Type: CRO/Service Provider for cellular based target engagement technologies

Location: Stockholm, Sweden Size: 53 employees Mission: All drug discovery projects should know their target(s) before entering clinical trials.

Key technology:Pelago Bioscience is a CRO that supports drug discovery, with expertise in target engagement in biologically relevant settings. Pelago Bioscience’s patented core technology, CETSA®(Cellular Thermal Shift Assay), provides confidence for early decision-making in all stages of the drug discovery pipeline.CETSA applications holds solutions from confirming target engagement and strengthening target validation, to hit generation for targets that are difficult to drug, selectivity profiling and elucidating the mechanism of action of compounds. CETSA enables greater understanding of how drugs perturb the biology in relevant models. Pelago’s extended team provide you with the insights you need to progress the right assets in your drug discovery pipeline.

DLRC is an award-winning, certified B Corporation consultancy team of >80 highly qualified and experienced professionals operating from offices in the UK, Germany, and US. With a deep commitment to excellence, we are dedicated to helping clients navigate the complex regulatory, HTA and market access landscape of the life science industry. We develop and execute innovative phase-appropriate strategies that connect regulatory planning, evidence generation, and access considerations, providing comprehensive support from early development to post-licensing activities for medicinal products. Our team brings together experts in nonclinical, CMC, clinical, HTA and market access, with experience from pharmaceutical and regulatory agencies.

J A Kemp is a firm packed with patent and trade mark attorneys at the top of their game, renowned for their technical excellence, human engagement and trusted advice.Innovation in biotechnology, chemistry, and pharmaceuticals is transforming lives and industries. Protecting these advancements requires not only a precise understanding of intellectual property law but also a deep appreciation for the science behind your work.J A Kemp’s expert patent attorneys combine unparalleled technical expertise with a collaborative, human approach to help businesses, brands and their advisers across the world to protect and defend their intellectual property, from ideas through to real-world solutions.

Celebrating One Year of Digital Medicine at the University of Bern!

The Department of Digital Medicine at the University of Bern turns one. Join us as we mark our first year, reflecting on what we've built together, and looking to the future we'll shape next.

Since its opening, DDM has brought together researchers, clinicians, innovators, and industry partners from across disciplines to advance digital medicine and improve healthcare for patients.

This special event will provide an opportunity to reflect on our achievements, recognise the people and collaborations that have shaped our journey, and explore what lies ahead for DDM and the future of digital medicine.

More information and program details are avaialble at: https://ddm-oneyear.ch

For any questions, please email info.ddm@unibe.ch.

We look forward to celebrating with you!

Join us for our next Leeds Digital Health event on the 19th November.

More details on topic and speakers to follow,

The flagship event for women's health innovation and technology

Get ready for an inspiring in-person gathering where innovation meets women's health, our second FemTech Germany Summit. Connect with trailblazers in technology, healthcare, and entrepreneurship as we explore the future of FemTech. Dive into exciting talks, hands-on workshops, and vibrant networking sessions. Whether you're a founder, investor, clinician or enthusiast, this summit is your chance to be part of the movement shaping the next wave of female-focused health tech. See you there!

At the DIGITAL HEALTH WORLD CONGRESS, discover the most influential thought leaders in digital health and immerse yourself in the latest innovations and groundbreaking trends redefining the healthcare landscape

Et gratis, samskabende kursus for fagpersoner i praksis og digitalt nysgerrige - om AI, sociale robotter og sundhedsdata, tillid og tryghed.

Et gratis, samskabende kursus for fagpersoner i praksis og digitalt nysgerrige

Sundhedsvæsenet digitaliseres hurtigere, end mange borgere kan følge med til. Klienter med svage sproglige kompetencer eller lav sundhedskompetence risikerer at blive tabt i mødet med MinLæge, digital post og et sundhedsvæsen, der forudsætter systemforståelse. “Fra digital til social” giver borgernære fagpersoner og digialt nysgerrige borgere konkrete greb til at spotte og støtte vejen mod en digital og social inklusion - som en forlængelse af Socialnavigatør-tankegangen vores arbejde i EU-PROMENS.

Kurset inddrager erfaringer og viden fra nyeste forskning og udvikling i bl.a. CARING-AI, MyHealth@MyHands, SHAFE Foundation og Mentastress.

Dive into the latest breakthroughs in MedTech and medical imaging with fellow innovators and tech enthusiasts!

MedTech Innovation: Smarter Imaging from Research to Clinical Practice

La French Tech Vienna is back with a session at the intersection of AI, MedTech, neuroscience and medical imaging. Hosted by the Medical University of Vienna, the event will give the floor to two cutting-edge startups — one from France and one from Austria — showing how smarter imaging can support clinical care, from more efficient breast MRI workflows to the diagnosis and monitoring of brain diseases.

TWO STARTUPS, TWO COMPLEMENTARY PERSPECTIVES

• Elmar Laistler — ALSIX · MedUni Wien
  Elmar Laistler is a physicist, co-founder of ALSIX and associate professor at MedUni Vienna, where he heads the Radio Frequency Lab. He will present ALSIX’s wearable breast coil, which enables supine breast MRI and aims to make breast cancer care faster, easier and more cost-effective.
• Ludovic de Rochefort — Founder & CEO, Ventio
  Ventio develops BriSE, an imaging software technology that uses data from routine scans to generate quantitative images of brain tissue. Its aim is to support earlier diagnosis and more consistent monitoring of neurodegenerative diseases. Ludovic holds a PhD in medical imaging and is an inventor of Quantitative Susceptibility Mapping (QSM).

PROGRAMME

16:00 — Welcome and refreshments

16:30 — Two pitches, followed by open discussion and networking

18:00 — Event ends

WHO SHOULD JOIN?

Radiologists, neurologists, researchers, investors, AI and life sciences startups, industry professionals and anyone curious about MedTech and medical imaging.

PRACTICAL INFORMATION

• Wednesday, 25 November 2026 · 16:00–18:00
• MedUni Campus AKH (exact room to be announced)
• Free entry. Registration is required.

Organised by La French Tech Vienna, connecting French entrepreneurs, startups and tech professionals with the Viennese and Austrian ecosystem.

Join us for an evening of insights, innovation and networking as IoTBelfast returns to Ulster University’s Belfast campus for our next meetup in November: IoT Belfast 36: IoT for MedTech, in partnership with the UU IEEE Student Branch and IEEE SMC Society (UK & Ireland Chapter).

This meetup will explore how the Internet of Things is transforming healthcare, from developing connected medical devices to making the AI and systems behind them more secure and trustworthy.

We’ll hear about the real-world challenges of taking a medical IoT product from prototype towards clinical use, including sensors, connectivity, cybersecurity and regulation. We'll also explore edge computing, digital twins and trustworthy AI, looking at how connected healthcare systems decide which device data to trust and how AI-powered devices can be attacked and defended.

Live MedTech Demos - Come Along Early!

Whether you’re a developer, engineer, researcher, technology professional, student or simply interested in IoT, MedTech, cybersecurity or AI, join us for practical insights from people working in the field, live MedTech demos, pizza and the chance to connect with Belfast’s IoT community!

About the Speakers & Topics
David Branagh | Raidmed
Bio: David Branagh is Founder and CEO of Raidmed, a Northern Ireland medtech company developing connected thermal monitoring technology to help prevent diabetic foot ulcers. A Chartered Engineer with an MEng and MBA, David has over 15 years’ experience in connected medical device development, engineering leadership and regulatory approvals, including at CHIC and Intelesens.

Talk: From IoT Prototype to Medical Device: The Challenges Beyond the Demo
Description: Building an IoT prototype that works is one thing. Developing a connected medical device suitable for clinical use is quite another. Drawing on Raidmed’s experience developing their at-home diabetic foot monitoring solution, David explores the practical engineering challenges, unexpected complications and trade-offs involving sensors, connectivity, usability, cybersecurity, clinical evidence and regulation on the journey from prototype towards clinical use.

Dr Aftab Ali | Ulster University
Bio: Dr Aftab Ali is a Lecturer in the School of Computing at Ulster University and a Fellow of Advance HE. His research focuses on cybersecurity, trustworthy AI, IoT, and digital twins. He collaborates with industry, supervises postgraduate research, and serves as Postgraduate Tutor and MSc Project Coordinator.

Talk: Securing Medical IoT at the Edge
Description: Connected medical devices, from glucose monitors to pacemakers, increasingly rely on edge hubs and digital twins. But a genuine device can still send data you shouldn’t believe. This talk shows how hardware identity, behavioural trust scoring and trust-weighted federated learning help edge systems decide which devices to trust, drawing on recent Ulster University research and real-world MedTech incidents.

Dr Rashid Kamal | Ulster University
Bio: Dr Rashid Kamal is a Lecturer in Computing at Ulster University. His Secure AI research looks at how AI systems in IoT and healthcare can be attacked, and how to protect them. He is Programme Committee Chair of MCETS 2026, a two-time Best Paper winner, and a NeurIPS reviewer.

Talk: When Smart Devices Can Be Fooled: Adversarial Attacks on IoT AI
Description: AI now runs inside cameras, wearables and smart sensors. But these models can be tricked. A small change in a signal, or a slight delay in timing, can make a device give the wrong answer. This talk shows real examples of such attacks on IoT and health devices, and explains simple ways to detect and defend against them.

Agenda:
6:30 pm - Doors open, live MedTech demos, pizza & informal networking!
7:00 pm - Welcome and introductions from Martin Naughton/Galvia Digital and Ulster University

7:10 pm - Talks begin

David Branagh - From IoT Prototype to Medical Device: The Challenges Beyond the Demo (15 minutes followed by 5 minutes of Q&A)

Dr Aftab Ali - Securing Medical IoT at the Edge (15 minutes followed by 5 minutes of Q&A)

Dr Rashid Kamal - When Smart Devices Can Be Fooled: Adversarial Attacks on IoT AI (15 minutes followed by 5 minutes of Q&A)

8:10 pm (Approximately) - Networking
9:15 pm - Event close & optional pints at the Sunflower Bar 🍻

Event Details
Venue: Conor Lecture Theatre, Room BA-01-009, Ulster University, Belfast Campus (Birley Building)
Date: Thursday, 26 November 2026
Time: 6:30 pm-9:15 pm
Host: Ulster University, in collaboration with the UU IEEE Student Branch and IEEE SMC Society (UK & Ireland Chapter).

The event will be held in the Birley Building (across from the main UU campus entrance). Upon arrival, attendees should make their way to the Conor Lecture Theatre, Room BA-01-009. We'll share any additional instructions with attendees before the event.

• Pizza will be provided.
• This event is facilitated by Martin Naughton and Galvia Digital. If you have any questions about the event, or if you’re interested in speaking at or hosting a future meetup, please get in touch.

Want to host or speak at an upcoming IoTBelfast event? Register your interest today!

Connecting European HealthTech Entrepreneurs and Investors.

THE FUTURE OF HEALTH IS TECH

This is a unique space, where healthtech, medtech, and digital solutions have the power to revolutionize people’s lives.

But moonshots need rockets, and rockets need fuel

Which is why we’re helping Europe’s brightest healthtech stars connect with investors and industry leaders aiming for real impact!

Europe's healthtech sector is growing, and we are all facing the same challenges. At the HealthTech Investor Summit, we bring together financers, entrepreneurs, mentors, experts and innovators. We will join forces and address today’s challeges while showcasing Europe’s finest healthtech innovations. The HealthTech Investor Summit in Bruges, will be an essential event for investors and innovators alike. Join us and get connected, share or find new insights and - last but not least - grow your innovations into market-ready products!

• European healthtech innovators looking to fund their great ideas: From pre-seed to scale-up, and medtech to digital applications – any company at the crossroads of health and tech is welcome!

• Investors looking for the next big healthtech star: From Europe or beyond, whether you’re from a family office, venture capitalist fund, or bank – come meet the rising stars of Europe’s health innovation!

• Clusters, companies, and organizations transforming healthcare: As a sponsor, knowledge partner, or event attendee, you can network, gain visibility, and help bring about the future of health!

• Anyone interested in transforming healthcare with technology

It's your gateway to finding investors and healthtech entrepreneurs alike. Here's what awaits you:

• Global networking: connect with like-minded healthtech innovators and entrepreneurs from across Europe and around the globe. Get a feel for untapped healthcare innovations and forge collaborations that transcend borders and open doors to international markets
• Investor connections: pitch your innovation to a curated audience of investors actively seeking the next big thing in healthtech. Secure funding, mentorship and strategic partnerships
• Expert insights: gain invaluable insights from industry leaders and influencers. Explore the latest trends, technologies and best practices that can propel your venture to new heights

Learn more at healthtechinvestorsummit.com

VALD Workshops are coming to Helsinki on December 2, 2026.

Tervetuloa työpajaan, jossa perehdymme siihen, miten teknologia ja objektiivinen data voivat tukea fysioterapeutteja kliinisessä päätöksenteossa, kuntoutuksen seurannassa ja suorituskyvyn kehittämisessä.

Työpajassa Marko Grönholm ja Markus Kuusela käsittelevät käytännönläheisesti, miten voimantuottoa, toimintakykyä ja kuntoutuksen etenemistä voidaan mitata ja seurata luotettavasti päätöksenteon tukena. Lisäksi tarkastelemme, kuinka dataa voidaan hyödyntää kuntoutuksen suunnittelussa ja harjoittelun ohjaamisessa.

Osallistujat pääsevät tutustumaan käytännön esimerkkeihin, keskustelemaan alan ajankohtaisista teemoista sekä tutustumaan VALDin järjestelmiin käytännössä.

Tapahtuman tiedot

Päivämäärä: 2.12.2026

Paikka: Urhea Campus, Helsinki

Aika: 14:00 - 18:00

Puhujat: Marko Grönholm & Markus Kuusela

Työpajan teemoja

• Objektiivisen datan hyödyntäminen fysioterapiassa
• Voiman ja toimintakyvyn mittaaminen käytännössä
• Kuntoutuksen edistymisen seuranta
• Teknologian mahdollisuudet kliinisessä työssä

E-Health+MVTe – Sweden's largest meeting place for everyone who leads, develops and streamlines e-health and wellness technologies

International exhibition of information technologies and telecommunications applied to the field of health

The 5th International Digital Health Summer School, May 11-12 Maynooth University, Stay Left Shift Left-10X - Revolutionizing Healthcare

Join us in person for the 5th International Digital Health Summer School to explore cutting-edge health tech!

Get ready to dive into the world of digital health this summer! This in-person Summer School brings together clinicians, technology experts, and innovators for a unique learning experience. Whether you're into tech, healthcare, or both, it's the perfect place to connect, learn, and have fun. Don’t miss out on this exciting opportunity to boost your knowledge and network with like-minded decision makers!

The Summer School is organized around key teaching points, elucidated with pragmatic real-life examples to help guide attendees to achieve real change in their organizations and across the complex adaptive system that is healthcare.

Maynooth University Certificate for attending.

Fee: €450 for 2 days

• Dates & Venue: May 11-12, 2027, John Hume Building, Maynooth University
• Host: Prof. Martin Curley, digital health pioneer and author of Stay Left Shift Left–10X (SL2-10X)
• Format: Two-day international learning and networking event bridging academia, health systems, industry, and policy (the “quadruple helix”).

• Theme: “Stay Left, Shift Left–10X” — accelerating health system transformation by moving care earlier, closer to home, and supported by digital innovation.Main Goals (“3 E’s”):
• Education – Access world-leading digital health learning
• Exploration – Build open collaboration and trust
• Exploitation – Identify and scale digital health innovations

• Artificial Intelligence in healthcare and data-driven care
• Digital oncology and precision medicine
• Electronic Health Records and patient data interoperability
• Digital sovereignty and cybersecurity
• Equitable access and affordability of care — addressing the “global model crisis” in health

TBC

• Meet cross-sector leaders shaping the next phase of digital health transformation.
• Learn directly from real-world implementation case studies of the SL2-10X model.
• Gain a network within a “high-trust, high-capability innovation community.”
• All delegates receive a copy of Prof Curley’s Stay Left, Shift Left–10X book and a Digital Health Academy Summer School certificate.
• Immerse in Maynooth’s new and historic campuses as backdrops to a fast-evolving digital health dialogue.